Navigation Links
TorkLaw Accepting DePuy Hip Implant Cases
Date:1/25/2013

LOS ANGELES, Jan. 25, 2013 /PRNewswire/ -- The Torkzadeh Law Firm (TorkLaw) is currently pursuing cases against Johnson & Johnson in regards to the defective DePuy ASR hip implants which were recalled in 2010.

As the first trial against Johnson & Johnson gets set to begin in California, newly unsealed court documents of pretrial testimony shows that the company had internal data and analysis that estimated failure in nearly 40 percent of all DePuy ASR Hip Implants.

The DePuy Hip Implants were released to the public in 2008 by Johnson & Johnson, and nearly 100,000 were implanted in patients around the world.  The Food and Drug Administration issued a recall in August 2010 citing the defective manufacturing procedures and unacceptably high failure rates.  There are currently over 10,000 lawsuits filed on behalf of individuals against J&J over its defective DePuy hip implants across the country.

"Since the litigation began against Johnson & Johnson, we are now seeing for the first time what data they had regarding the safety and integrity of their DePuy hip implants.  It is rather alarming what they decided to do with that information," said Reza Torkzadeh , lead product liability lawyer at TorkLaw.

Internal documents and pretrial testimony by J&J representatives show data and analysis of a failure rate of nearly 40% in about four and a half years.  Representatives for J&J previously disputed such failure rates.

"Thousands of individuals have been severely impacted by these defective hip implants.  Most will be living with pain forever, have gone through a serious revision surgery and others won't ever be the same again.  It's time that the truth came out, and that companies like Johnson & Johnson are held accountable for the products they intend to sell to the public.  We must send a message that their profits cannot come at the expense of consumers lives and wellbeing" said Torkzadeh, who's law firm is actively pursuing DePuy Hip Implant cases.

TorkLaw is an award winning nationally recognized personal injury law firm focused on representing victims of defective products and medical devices, dangerous pharmaceuticals, catastrophic injury and wrongful death claims.  For more information on the DePuy hip implant recall and lawsuits call now for a free consultation 888.222.8286 or www.torklaw.com


'/>"/>
SOURCE The Torkzadeh Law Firm
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TorkLaw Accepting St. Jude Medical Device Cases
2. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
3. Fogarty Institute for Innovation Accepting Applications for Advanced Endovascular Training Fellowship
4. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
5. DePuy Settlement News In Bellwether Case Concerns Plaintiffs Of The Hip Recall
6. DePuy Mitek Expands Commitment To Youth Sports Safety Through New Sports Injury Prevention Program
7. Sports Injury Prevention Program, Sponsored By DePuy Mitek, Comes To Tampa With Soccer Star Heather Mitts
8. DePuy Settlement Funding And Transvaginal Mesh Capital Increased At Legal-Bay
9. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
10. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
11. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):